Elsevier Releases Pathway Studio Web Plant; a Powerful New Solution to Improve Global Research on Critical Crop Production and Protection
NEW YORK, October 8, 2013 /PRNewswire/ –
Flexible informatics solution provides commercial and academic plant
researchers with a comprehensive knowledgebase of molecular information from the top
world-leading provider of scientific, technical and medical information products and
services, today announced the release of Pathway Studio Web Plant
. This web-based research solution helps plant
scientists explore breeding through trait analysis, and enables them to make more informed
decisions at critical stages of crop production and protection research.
Plant researchers are applying genomics information to address the urgent needs of
sustaining production – maximizing yield in difficult conditions, and protecting crops in
environmentally safe ways. To meet these challenges, they require access to molecular
information on beneficial traits, and to analytical tools that interpret reference and
Pathway Studio Web Plant has a unique knowledgebase of molecular relationships and
curated pathways from three model plant organisms: Arabidopsis, Maize, and Rice. It also
provides powerful analytical and visualization tools, that help plant biologists
contextualize complex biology involved in conditions that affect crop yield, such as
drought sensitivity and disease resistance.
“Pathway Studio Plant, which is also available as an Enterprise solution, is an
important technology to advance research on crop breeding and sustainability,” said Jaqui
Hodgkinson, Vice President of Product Development, Life Science Solutions, Elsevier. “The
web version of Pathway Studio Plant enables access for even more plant researchers in
academic and commercial institutions worldwide. The Enterprise edition of Pathway Studio
adds additional advanced functionality to support plant breeding research, and the ability
for researchers to create in-house plant databases.”
Currently the Pathway Studio Plant knowledge base contains information on more than
130,000 molecular interactions, extracted from 60,000 full text plant-specific articles.
Maintained by Elsevier and updated weekly as part of the subscription agreement, the
Pathway Studio knowledgebase and pathway collections summarize the state of current
research on Arabidopsis, Maize, and Rice.
With Pathway Studio Plant, researchers now have a single solution that combines
disparate information found across many different public databases. With its filtering and
inferred relationship capabilities plant researchers can rapidly annotate hundreds of
proteins and reconstruct hundreds of pathways, expanding the depth and breadth of
scientific enquiry for their plant of choice, and supporting confident research decisions.
Pathway Studio Plant is a part of Elsevier’s Life Science Solutions, a suite of
interoperable, domain-specific, decision support tools which span the discovery and
development workflow; including ScienceDirect, Scopus, TargetInsights, Reaxys, Reaxys
Medicinal Chemistry, PharmaPendium, QUOSA and Embase.
For further information go to elsevier.com/pathway-studio
About Pathway Studio
A robust informatics solution, Pathway Studio provides scientists with an unparalleled
knowledge base of molecular interactions drawn from literature-based evidence. Integrated
data mining, analytical, and visualization capabilities rapidly connect relevant
biological relationships and interpret experimental data. Presented in a visual context,
results can be used to define and test in silico-based hypotheses across a wide range of
disciplines, increasing efficiency and research confidence. For more information, got to:
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], SciVal [http://info.scival.com ], Reaxys
[http://www.elsevier.com/reaxys ], ClinicalKey [https://www.clinicalkey.com ] and Mosby’s
Suite [http://www.confidenceconnected.com ], which enhance the productivity of science and
health professionals, helping research and health care institutions deliver better
outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world leading provider of professional information
solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact Liz Griffioen Elsevier +31-20-485-2247 L.email@example.com